Skip to main navigation Skip to search Skip to main content

Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?

  • Olivier Kosmider
  • , Marie Passet
  • , Valeria Santini
  • , Uwe Platzbecker
  • , Valérie Andrieu
  • , Gina Zini Tanzi
  • , Odile Beyne-Rauzy
  • , Agnès Guerci
  • , Erico Masala
  • , Enrico Balleari
  • , Ekaterina Bulycheva
  • , François Dreyfus
  • , Pierre Fenaux
  • , Michaela Fontenay
  • , Sophie Park
  • Université Paris Cité
  • University of Florence
  • Technische Universität Dresden (TU Dresden)
  • Oncopole
  • Hôpital d'adultes de Brabois
  • San Martino Hospital Genoa
  • Université Grenoble Alpes

Research output: Contribution to journalArticle

Abstract

no
Original languageEnglish
Pages (from-to)e280-e283
Number of pages3
JournalHaematologica
Volume101
DOIs
Publication statusPublished - 2016

Keywords

  • Cytogenetics and molecular genetics
  • Hematology
  • Myelodysplastic syndromes
  • Red cells

Fingerprint

Dive into the research topics of 'Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?'. Together they form a unique fingerprint.

Cite this